The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial and/or institutional partners, in order to serve the patient needs and for the benefit of the society, as well as to contribute to sustainability of the Institut Pasteur’s resources.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
L. Deriano and D.B. Roth. Modernizing the Nonhomologous End Joining Repertoire: Alternative and Classical NHEJ Share The Stage.Annual Review of Genetics. 2013 Nov 23;47:433-55.
M. Coussens, R.L. Wendland, L. Deriano, C. Lindsay, S.M. Arnal, D.B. Roth. RAG2’s acidic hinge restricts repair-pathway choice and promotes genomic stability. Cell Reports. 2013 Sep 12; 4(5):870-8.
J. Chaumeil, M. Micsinai, P. Ntziachristos, D.B. Roth, I. Aifantis, Y. Kluger, L. Deriano, J.A. Skok. The C-terminus of RAG2 and ATM control RAG activity to limit the number of potential translocation substrates. Nature Communications. 2013 Jul 31; 4:2231.
J. Chaumeil, M. Micsinai, P. Ntziachristos, L. Deriano, J. M. Wang, Y. Ji, E.P. Nora, M.J. Rodesch, J.A. Jeddeloh, I. Aifantis, Y. Kluger, D.G. Schatz, J.A. Skok. Higher-order looping and nuclear organization of antigen receptor loci facilitate targeted RAG cleavage and regulated rearrangement in recombination centers. Cell Reports. 2013 Feb 21; 3(2):359-70.
M. Mijušković, S.M. Brown, Z. Tang, C.R. Lindsay, E. Efstathiadis, L.Deriano, D.B. Roth. A streamlined method for detecting structural variants in cancer genomes by short read paired-end sequencing.PLoS One. 2012 Oct 29; 7(10):e48314.
L. Deriano, J. Chaumeil, M. Coussens, A. Multani, Y. Chou, A.V. Alekseyenko, S. Chang, J.A. Skok, D.B. Roth. The RAG2 C-terminus suppresses genomic instability and lymphomagenesis. Nature. 2011 Mar 3; 471(7336): 119-2.
L. Deriano, T.H. Stracker, A. Baker, J.H.J. Petrini, D.B. Roth. Roles for NBS1 in alternative end joining of V(D)J recombination intermediates. Mol Cell. 2009 Apr 10; 34(1): 13-25.
T. H. Stracker, B. R. Williams, L. Deriano, J. W. Theunissen, C. A. Adelman, D. B. Roth, J.H. Petrini. Artemis and nonhomologous end joining-independent influence of DNA-dependent protein kinase catalytic subunit on chromosome stability. Mol Cell Biol. 2009 Jan; 29(2): 503-14.
B. Corneo*, R.L. Wendland*, L. Deriano*, X. Cui, I.A. Klein, S. Wong, S. Arnal, A.J. Holub, G.R. Weller, B.A. Pancake, S. Shah, V.L. Brandt, K. Meek, D.B. Roth. RAG mutations reveal robust alternative end joining. Nature, 2007 Sep; 449(7161): 483-6. (*Equal contribution)
F. Delacôte, L. Deriano, S. Lambert, P. Bertrand, Y. Saintigny, B. S. Lopez. Chronic exposure to sublethal doses of radiation mimetic Zeocintrade mark selects for clones deficient in homologous recombination. Mutat Res, 2007 Feb 3; 615(1-2): 125-33.
L. Deriano, H. Merle-Beral, O. Guipaud, L. Sabatier, J. Delic. Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells. Br J Haematol. 2006 Jun; 133(5): 520-5.
J. Bouley, L. Deriano, J. Delic, H. Merle-Beral. New molecular markers in resistant B-CLL. Leuk Lymphoma. 2006 May; 47(5): 791-801.
L. Deriano, O. Guipaud, H. Merle-Béral, J. L. Binet, M. Ricoul, V. Favaudon, C. Muller, B. Salles, L. Sabatier and J. Delic. Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood. 2005 Jun 15; 105(12): 4776-83.
O. Guipaud, L. Deriano, H. Salin, L. Vallat, L. Sabatier, H. Merle-Béral and J. Delic. B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features. Lancet Oncol. 2003 Aug; 4(8):505-14.
I. Pombo, S. Martin-Verdeaux, B. Iannascoli, J. Le Mao, L. Deriano, J. Rivera, U. Blank. IgE receptor type I-dependent regulation of a Rab3D-associated kinase: a possible link in the calcium-dependent assembly of SNARE complexes. J Biol Chem. 2001 Nov 16; 276(46): 42893-900.
Updated on 14/02/2014
Our laboratory is located on the 4th floor of the Bâtiment Metchnikoff (building #67 on the map below), room 4022, on the Institut Pasteur Paris campus.
The nearest subway station is “Pasteur” on the lines 6 and 12.
Ludovic Deriano, Ph.D.
G5 Lymphocyte Development and Oncogenesis
Immunology Department – Metchnikoff building (#67)